Opaleye Management Inc. Q1 2019 Filing
Filed May 15, 2019
Portfolio Value
$361.1M
Holdings
53
Report Date
Q1 2019
Filing Type
13F-HR
All Holdings (53 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | CDXSCODEXIS INC | 1,475,000 | $30.3M | 8.39% | |
| 2 | AXGNAXOGEN INC | 1,100,000 | $23.2M | 6.41% | |
| 3 | —EPIZYME INC | 1,365,000 | $16.9M | 4.68% | |
| 4 | —CERECOR INC | 2,300,000 | $13.4M | 3.72% | |
| 5 | AMRNAMARIN CORP PLC | 645,000 | $13.4M | 3.71% | |
| 6 | QUREUNIQURE NV | 205,000 | $12.2M | 3.39% | |
| 7 | ASNDASCENDIS PHARMA A S | 95,000 | $11.2M | 3.10% | |
| 8 | TGTXTG THERAPEUTICS INC | 1,366,062 | $11.0M | 3.04% | |
| 9 | —AUDENTES THERAPEUTICS INC | 280,000 | $10.9M | 3.03% | |
| 10 | FGENEURFIBROGEN INC | 200,000 | $10.9M | 3.01% | |
| 11 | —CLEMENTIA PHARMACEUTICALS INC | 400,130 | $10.4M | 2.89% | |
| 12 | 2L9BLUEPRINT MEDICINES CORP | 130,000 | $10.4M | 2.88% | |
| 13 | NVTA1EURINVITAE CORP | 440,000 | $10.3M | 2.85% | |
| 14 | CPRXCATALYST PHARMACEUTICALS INC | 1,825,000 | $9.3M | 2.58% | |
| 15 | —HARROW HEALTH | 1,800,000 | $9.0M | 2.48% | |
| 16 | —MAGENTA THERAPEUTICS INC | 510,000 | $8.4M | 2.33% | |
| 17 | PTCTPTC THERAPEUTICS INC | 213,800 | $8.0M | 2.23% | |
| 18 | DCPHEURDECIPHERA PHARMACEUTICALS IN | 340,000 | $7.9M | 2.19% | |
| 19 | MRTXEURMIRATI THERAPEUTICS INC | 105,000 | $7.7M | 2.13% | |
| 20 | OCULOCULAR THERAPEUTIX INC | 1,900,000 | $7.5M | 2.09% | |
| 21 | CBAYUSDCYMABAY THERAPEUTICS INC | 550,000 | $7.3M | 2.02% | |
| 22 | —ODONATE THERAPEUTICS INC | 325,000 | $7.2M | 1.99% | |
| 23 | CYTKCYTOKINETICS | 850,000 | $6.9M | 1.90% | |
| 24 | 1T7TRICIDA INC | 165,000 | $6.4M | 1.76% | |
| 25 | ETONETON PHARMACEUTICALS INC | 764,773 | $6.1M | 1.69% | |
| 26 | —STRONGBRIDGE BIOPHARMA PLC | 1,152,500 | $5.7M | 1.59% | |
| 27 | —DERMIRA INC | 400,000 | $5.4M | 1.50% | |
| 28 | ACADACADIA PHARMACEUTICALS INC | 200,000 | $5.4M | 1.49% | |
| 29 | XOMAXOMA CORP DEL | 400,000 | $5.0M | 1.37% | |
| 30 | —HORIZON PHARMA PLC | 185,000 | $4.9M | 1.35% | |
| 31 | VKTXVIKING THERAPEUTICS INC | 485,000 | $4.8M | 1.33% | |
| 32 | —EIDOS THERAPEUTICS INC | 200,000 | $4.7M | 1.30% | |
| 33 | —RETROPHIN INC | 205,000 | $4.6M | 1.28% | |
| 34 | —ABEONA THERAPEUTICS INC | 560,000 | $4.1M | 1.14% | |
| 35 | CARAEURCARA THERAPEUTICS INC | 200,000 | $3.9M | 1.09% | |
| 36 | —AVENUE THERAPEUTICS INC | 800,000 | $3.8M | 1.05% | |
| 37 | —AIMMUNE THERAPEUTICS INC | 165,000 | $3.7M | 1.02% | |
| 38 | —FORTRESS BIOTECH INC | 2,000,000 | $3.6M | 0.99% | |
| 39 | —ACORDA PHARMACEUTICALS | 265,000 | $3.5M | 0.98% | |
| 40 | SWAVUSDSHOCKWAVE MED INC | 92,100 | $3.1M | 0.85% | |
| 41 | FRXFENNEC PHARMACEUTICALS INC | 630,000 | $3.1M | 0.85% | |
| 42 | —CIDARA THERAPEUTICS INC | 1,000,000 | $2.6M | 0.73% | |
| 43 | LQDALIQUIDIA TECHNOLOGIES INC | 225,000 | $2.6M | 0.71% | |
| 44 | APLSAPELLIS PHARMACEUTICALS INC | 115,000 | $2.2M | 0.62% | |
| 45 | CMRXEURCHIMERIX INC | 960,000 | $2.0M | 0.56% | |
| 46 | CRNXCRINETICS PHARMACEUTICALS INC | 73,000 | $1.7M | 0.46% | |
| 47 | ESTAESTABLISHMENT LABS HLDGS INC | 50,000 | $1.2M | 0.33% | |
| 48 | —ZYMEWORKS INC | 55,000 | $890K | 0.25% | |
| 49 | —SYNTHORX INC | 40,000 | $815K | 0.23% | |
| 50 | —FOAMIX PHARMACEUTICALS LTD | 180,000 | $675K | 0.19% | |
| 51 | KURAKURA ONCOLOGY INC | 25,200 | $418K | 0.12% | |
| 52 | —LA JOLLA PHARMACEUTICAL CO | 60,000 | $386K | 0.11% | |
| 53 | —BIOLINERX LTD | 250,000 | $108K | 0.03% |